Lv11
46 积分 2025-01-02 加入
Expanding access to CAR T cell therapies through local manufacturing
4小时前
已完结
Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells
4小时前
已完结
Efficient manufacturing of CAR-T cells from whole blood: a scalable approach to reduce costs and enhance accessibility in cancer therapy
9天前
已完结
Efficient manufacturing of CAR-T cells from whole blood: a scalable approach to reduce costs and enhance accessibility in cancer therapy
14天前
已完结
Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy®: real-world experience and cost analysis in India
1个月前
已完结
Improved closed and automated workflow for GMP-compliant CAR-T manufacturing of cell-based medicinal products using a new generation CliniMACS Prodigy Tubing Set
1个月前
已完结
ENABLING SCALABLE AND AFFORDABLE AUTOLOGOUS CELL THERAPIES VIA AUTOMATED MULTIPLEXED CLOSED SYSTEMS
1个月前
已完结
Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors
4个月前
已完结
皖公网安备34019202002308
